These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19303877)

  • 1. Functional genomics and proteomics approaches to study the ERBB network in cancer.
    Sahin O; Wiemann S
    FEBS Lett; 2009 Jun; 583(11):1766-71. PubMed ID: 19303877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and proteomics approaches in understanding tumor angiogenesis.
    Mittal V; Nolan DJ
    Expert Rev Mol Diagn; 2007 Mar; 7(2):133-47. PubMed ID: 17331062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research.
    Dasgupta R; Perrimon N
    Oncogene; 2004 Nov; 23(51):8359-65. PubMed ID: 15517017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer genomics object model: an object model for multiple functional genomics data for cancer research.
    Park YR; Lee HW; Cho SB; Kim JH
    Stud Health Technol Inform; 2007; 129(Pt 2):1235-9. PubMed ID: 17911912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HepatoProteomics: applying proteomic technologies to the study of liver function and disease.
    Diamond DL; Proll SC; Jacobs JM; Chan EY; Camp DG; Smith RD; Katze MG
    Hepatology; 2006 Aug; 44(2):299-308. PubMed ID: 16871559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics and proteomics in predicting cancer outcomes.
    Parikh AA; Johnson JC; Merchant NB
    Surg Oncol Clin N Am; 2008 Apr; 17(2):257-77, vii. PubMed ID: 18375352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming omics data into context: bioinformatics on genomics and proteomics raw data.
    Perco P; Rapberger R; Siehs C; Lukas A; Oberbauer R; Mayer G; Mayer B
    Electrophoresis; 2006 Jul; 27(13):2659-75. PubMed ID: 16739231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging biomarker technologies.
    Gunn L; Smith MT
    IARC Sci Publ; 2004; (157):437-50. PubMed ID: 15055310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof concept for clinical justification of network mapping for personalized cancer therapeutics.
    Nemunaitis J; Senzer N; Khalil I; Shen Y; Kumar P; Tong A; Kuhn J; Lamont J; Nemunaitis M; Rao D; Zhang YA; Zhou Y; Vorhies J; Maples P; Hill C; Shanahan D
    Cancer Gene Ther; 2007 Aug; 14(8):686-95. PubMed ID: 17541424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic approaches in cancer risk and response assessment.
    Petricoin EF; Liotta LA
    Trends Mol Med; 2004 Feb; 10(2):59-64. PubMed ID: 15102358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of functional genomics and proteomics to the study of immune responses in the Pacific white leg shrimp Litopenaeus vannamei.
    Robalino J; Carnegie RB; O'Leary N; Ouvry-Patat SA; de la Vega E; Prior S; Gross PS; Browdy CL; Chapman RW; Schey KL; Warr G
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):110-8. PubMed ID: 19070907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approaches to study plant-pathogen interactions.
    Quirino BF; Candido ES; Campos PF; Franco OL; Krüger RH
    Phytochemistry; 2010 Mar; 71(4):351-62. PubMed ID: 20005547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical cancer genetics, genomics and proteomics.
    Gruber MP; Geraci MW
    J Insur Med; 2005; 37(3):190-200. PubMed ID: 16259209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting cancer pathways and vulnerabilities with RNAi.
    Westbrook TF; Stegmeier F; Elledge SJ
    Cold Spring Harb Symp Quant Biol; 2005; 70():435-44. PubMed ID: 16869781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genomics: integrating form and function.
    Kim SY; Hahn WC
    Carcinogenesis; 2007 Jul; 28(7):1387-92. PubMed ID: 17434922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics and genomics of microgravity.
    Nichols HL; Zhang N; Wen X
    Physiol Genomics; 2006 Aug; 26(3):163-71. PubMed ID: 16705019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology, chemogenomics and chemoproteomics.
    Gagna CE; Winokur D; Clark Lambert W
    Cell Biol Int; 2004; 28(11):755-64. PubMed ID: 15563397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics and proteomics in neoplasia.
    Baak JP; Mohan H
    Indian J Pathol Microbiol; 2007 Jan; 50(1):1-5. PubMed ID: 17474244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.